Dr Gerd Michael Maier, Boehringer Ingelheim
In the pharmaceutical industry, drug dissolution testing is routinely used as a key test parameter for assessing the performance of solid and semi-solid dosage forms in both drug development and quality control. A dissolution test measures the amount of drug that goes into solution over a period of time under standardized conditions. It is used to assure batch-to-batch quality, to provide process control, and to substitute in vivo studies under certain circumstances.
This webinar targets executives and staff in development and quality control in the pharmaceutical industry. The webinar is also intended for participants from quality assurance, regulatory affairs as well as contract laboratories.
For our webinars, we use Cisco WebEx, one of the leading suppliers of online meetings. At http://www.webex.com/test-meeting.html
you can check if your system meets the necessary requirements for the participation at a WebEx meeting and at the same time install the necessary plug-in. Please just enter your name and email address for the test. If the installation is not possible because of your rights for the computer system, please contact your IT department. WebEx is a standard nowadays and the necessary installation is fast and easy.
This webinar aims at providing delegates with a sound understanding of the principles and practices in dissolution testing.
The following topics will be covered:
- Dissolution technique
- Factors affecting dissolution
- Regulatory requirements (general guidelines, USP, EP)
- Dissolution methods and apparatus
- Dissolution automation
- Qualification of dissolution apparatuses
- Development of dissolution methods
Recording from 04.09.2020
Duration of recording: about 1,5 h.